199 related articles for article (PubMed ID: 25786478)
1. Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility.
Farrukee R; Leang SK; Butler J; Lee RT; Maurer-Stroh S; Tilmanis D; Sullivan S; Mosse J; Barr IG; Hurt AC
J Antimicrob Chemother; 2015 Jul; 70(7):2004-12. PubMed ID: 25786478
[TBL] [Abstract][Full Text] [Related]
2. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
[TBL] [Abstract][Full Text] [Related]
3. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.
Takashita E; Meijer A; Lackenby A; Gubareva L; Rebelo-de-Andrade H; Besselaar T; Fry A; Gregory V; Leang SK; Huang W; Lo J; Pereyaslov D; Siqueira MM; Wang D; Mak GC; Zhang W; Daniels RS; Hurt AC; Tashiro M
Antiviral Res; 2015 May; 117():27-38. PubMed ID: 25721488
[TBL] [Abstract][Full Text] [Related]
4. Mutations at the monomer-monomer interface away from the active site of influenza B virus neuraminidase reduces susceptibility to neuraminidase inhibitor drugs.
Fujisaki S; Imai M; Takashita E; Taniwaki T; Xu H; Kishida N; Yokoyama M; Sato H; Tashiro M; Odagiri T
J Infect Chemother; 2013 Oct; 19(5):891-5. PubMed ID: 23529501
[TBL] [Abstract][Full Text] [Related]
5. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.
Gubareva LV; Besselaar TG; Daniels RS; Fry A; Gregory V; Huang W; Hurt AC; Jorquera PA; Lackenby A; Leang SK; Lo J; Pereyaslov D; Rebelo-de-Andrade H; Siqueira MM; Takashita E; Odagiri T; Wang D; Zhang W; Meijer A
Antiviral Res; 2017 Oct; 146():12-20. PubMed ID: 28802866
[TBL] [Abstract][Full Text] [Related]
6. Characterization of influenza B viruses with reduced susceptibility to influenza neuraminidase inhibitors.
Brown SK; Tseng YY; Aziz A; Baz M; Barr IG
Antiviral Res; 2022 Apr; 200():105280. PubMed ID: 35304163
[TBL] [Abstract][Full Text] [Related]
7. Influenza B viruses from different genetic backgrounds are variably impaired by neuraminidase inhibitor resistance-associated substitutions.
Pascua PNQ; Marathe BM; Bisen S; Webby RJ; Govorkova EA
Antiviral Res; 2020 Jan; 173():104669. PubMed ID: 31790712
[TBL] [Abstract][Full Text] [Related]
8. A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.
Fujisaki S; Takashita E; Yokoyama M; Taniwaki T; Xu H; Kishida N; Sato H; Tashiro M; Imai M; Odagiri T
Biochem Biophys Res Commun; 2012 Dec; 429(1-2):51-6. PubMed ID: 23131559
[TBL] [Abstract][Full Text] [Related]
9. Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.
Wang D; Sleeman K; Huang W; Nguyen HT; Levine M; Cheng Y; Li X; Tan M; Xing X; Xu X; Klimov AI; Gubareva LV; Shu Y
Antiviral Res; 2013 Mar; 97(3):240-4. PubMed ID: 23267831
[TBL] [Abstract][Full Text] [Related]
10. Substitutions at H134 and in the 430-loop region in influenza B neuraminidases can confer reduced susceptibility to multiple neuraminidase inhibitors.
Mohr PG; Williams J; Tashiro M; Streltsov VA; McKimm-Breschkin JL
Antiviral Res; 2020 Oct; 182():104895. PubMed ID: 32750469
[TBL] [Abstract][Full Text] [Related]
11. [Susceptibility of Influenza B Viruses to Neuraminidase Inhibitors Isolated during 2013-2014 Influenza Season in Mainland China].
Huang W; Li X; Tan M; Wei H; Cheng Y; Guo J; Wang Z; Xiao N; Wang D; Shu Y
Bing Du Xue Bao; 2015 Mar; 31(2):152-6. PubMed ID: 26164940
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and Susceptibility to Neuraminidase Inhibitors in Individuals Infected With Different Influenza B Lineages: The Influenza Resistance Information Study.
van der Vries E; Ip DK; Cowling BJ; Zhang JD; Tong X; Wojtowicz K; Schutten M; Boucher CA
J Infect Dis; 2016 Jan; 213(2):183-90. PubMed ID: 26160744
[TBL] [Abstract][Full Text] [Related]
13. Neuraminidase inhibitor susceptibility profile of human influenza viruses during the 2016-2017 influenza season in Mainland China.
Huang W; Cheng Y; Li X; Tan M; Wei H; Zhao X; Xiao N; Dong J; Wang D
J Infect Chemother; 2018 Sep; 24(9):729-733. PubMed ID: 29866491
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
[TBL] [Abstract][Full Text] [Related]
15. Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.
Burnham AJ; Baranovich T; Marathe BM; Armstrong J; Webster RG; Govorkova EA
Antimicrob Agents Chemother; 2014 May; 58(5):2718-30. PubMed ID: 24566185
[TBL] [Abstract][Full Text] [Related]
16. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
[TBL] [Abstract][Full Text] [Related]
17.
Jeong JH; Choi WS; Antigua KJC; Choi YK; Govorkova EA; Webby RJ; Baek YH; Song MS
J Virol; 2020 Dec; 95(1):. PubMed ID: 33055248
[TBL] [Abstract][Full Text] [Related]
18. Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.
Little K; Leang SK; Butler J; Baas C; Harrower B; Mosse J; Barr IG; Hurt AC
Euro Surveill; 2015; 20(45):. PubMed ID: 26608955
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors.
Gubareva LV
Virus Res; 2004 Jul; 103(1-2):199-203. PubMed ID: 15163510
[TBL] [Abstract][Full Text] [Related]
20. Peramivir susceptibilities of recombinant influenza A and B variants selected with various neuraminidase inhibitors.
Fage C; Tu V; Carbonneau J; Abed Y; Boivin G
Antivir Ther; 2017; 22(8):711-716. PubMed ID: 29082897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]